90 research outputs found
Correction: Distribution of moniliformin in industrial maize milling and flaking process (Mycotoxin Research, (2024), 40, 4, (659-665), 10.1007/s12550-024-00560-3)
No full textIn the original version of this article, the given and family names of "Terenzio Bertuzzi, Alessio Abate, Paola Giorni" were incorrectly structured. Given here are the corrected author names. The original article has been corrected
Una protesta senza movimento? L’animalismo in Italia e la centralità dell’advocacy individuale
No full textThe article investigates forms of organized interest for animal rights and wellbeing. The field consists in a variegated composition of individual and collective actors, quite different in terms of ideological values and action strategies. The author presents a historical overview of the phenomenon during the twentieth century. However, the main focus of the paper is on the present situation, and specifically on the importance assumed by the personal action frames and individual repertoires of contention. Through an online survey (704 responses) and 20 semi-structured interviews, the author frames animal advocacy within a number of typical characteristics of modernity, and especially the process of individualization. Considering these elements, the forms of protest and advocacy are widespread, while an actual movement identity is in crisis
Imatinib mesylate in desmoplastic small round cell tumors
No full text Aim: To investigate the possible role of imatinib, an inhibitor of the tyrosine kinase activity of PDGF-R, in desmoplastic small round cell tumor (DSRCT). Patients & methods: From August 2005 to June 2009, DSRCT patients refractory to conventional treatment were enrolled. Patients received imatinib 400 mg daily. Primary end point of this open label, prospective, Phase II trial was objective response rate. Results: Of the 13 enrolled patients, eight were evaluable for response. Median age was 20 years (range: 9–32). Objective responses at 3 months were: stable disease in one patient and progressive disease in seven patients. Conclusion: Imatinib showed no efficacy in the treatment of DSRCT unresponsive to conventional therapy, despite molecular-based selection of patients. </jats:p
Juxtaglomerular cell tumor: Multicentric synchronous disease associated with paraneoplastic syndrome
No full textEfficacy of trabectedin in advanced soft tissue sarcoma: Beyond lipo- and leiomyosarcoma
No full textNon-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial
No full textNon-pegylated liposomal doxorubicin (NPLD) has demonstrated antitumour activity equivalent to conventional doxorubicin and a significantly lower risk of cardiotoxicity. This phase II trial was performed to evaluate the activity and the safety of NPLD and ifosfamide combination in patients with metastatic soft tissue sarcoma
sj-docx-1-tam-10.1177_17588359231225028 – Supplemental material for Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry
No full textSupplemental material, sj-docx-1-tam-10.1177_17588359231225028 for Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry by Bruno Vincenzi, Alessio Cortellini, Alessandro Mazzocca, Sarah Orlando, Davide Romandini, Juan Aguilar-Company, Isabel Ruiz-Camps, Claudia Valverde Morales, Simeon Eremiev-Eremiev, Carlo Tondini, Joan Brunet, Rossella Bertulli, Salvatore Provenzano, Mark Bower, Daniele Generali, Ramon Salazar, Anna Sureda, Aleix Prat, Michalarea Vasiliki, Mieke Van Hemelrijck, Ailsa Sita-Lumsden, Alexia Bertuzzi, Sabrina Rossi, Amanda Jackson, Federica Grosso, Alvin J. X. Lee, Cian Murphy, Katherine Belessiotis, Uma Mukherjee, Fanny Pommeret, Angela Loizidou, Gianluca Gaidano, Gino M. Dettorre, Salvatore Grisanti, Marco Tucci, Claudia A. M. Fulgenzi, Alessandra Gennari, Andrea Napolitano and David J. Pinato in Therapeutic Advances in Medical Oncology</p
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry.
No full textretrospective, registry study David J Pinato, Josep Tabernero, Mark Bower, Lorenza Scotti, Meera Patel, Emeline Colomba, Saoirse Dolly, Angela Loizidou, John Chester, Uma Mukherjee, Alberto Zambelli, Alessia Dalla Pria, Juan Aguilar-Company, Diego Ottaviani, Amani Chowdhury, Eve Merry, Ramon Salazar, Alexia Bertuzzi, Joan Brunet, Matteo Lambertini, Marco Tagliamento, Anna Pous, Ailsa Sita-Lumsden, Krishnie Srikandarajah, Johann Colomba, Fanny Pommeret, Elia Segui, Daniele Generali, Salvatore Grisanti, Paolo Pedrazzoli, Gianpiero Rizzo, Michela Libertini, Charlotte Moss, Joanne S Evans, Beth Russell, Nadia Harbeck, Bruno Vincenzi, Federica Biello, Rossella Bertulli, Raquel Lilian, Sabrina Rossi, Maria Carmen Carmona-Garcia, Carlo Tondini, Laura Fox, Alice Baggi, Vittoria Fotia, Alessandro Parisi, Giampero Porzio, Maristella Saponara, Claudia Andrea Cruz, David Garcia-Illescas, Eudald Felip, Ariadna Roque Lloveras, Rachel Sharkey, Elisa Roldan, Roxana Reyes, Irina Earnshaw, Daniela Ferrante, Javier Marco-Hernandez, Isabel Ruiz-Camps, Gianluca Gaidano, Andrea Patriarca, Riccardo Bruna, Anna Sureda, Clara Martinez-Vila, Ana Sanchez de Torre, Luca Cantini, Marco Filetti, Lorenza Rimassa, Lorenzo Chiudinelli, Michela Franchi, Marco Krengli, Armando Santoro, Aleix Prat, Mieke Van Hemelrijck, Nikolaos Diamantis, Thomas Newsom-Davis, Alessandra Gennari, Alessio Cortellini, on behalf of the OnCovid study group
Contrast Enhanced EUS for Predicting Solid Pancreatic Neuroendocrine Tumor Grade and Aggressiveness
No full textPancreatic neuroendocrine tumor (PNET) behavior assessment is a daily challenge for physicians. Modern PNET management varies from a watch-and-wait strategy to surgery depending on tumor aggressiveness. Therefore, the aggressiveness definition plays a pivotal role in the PNET work-up. The aggressiveness of PNETs is mainly based on the dimensions and histological grading, with sometimes a lack of specificity and sensibility. In the last twenty years, EUS has become a cornerstone in the diagnostic phase of PNET management for its high diagnostic yield and the possibility of obtaining a histological specimen. The number of EUS applications in the PNET work-up has been rapidly increasing with new and powerful possibilities. The application of contrast has led to an important step in PNET detection; in recent years, it has been gaining interesting applications in aggressiveness assessment. In this review, we underline the latest experiences and opportunities in the behavior assessment of PNETs using contact-enhanced EUS and contested enhanced harmonic EUS with a particular focus on the future application and possibility that these techniques could provide
A Contribution to the Biography of Hvar\u27s Canon Andrew Bartučević (Bertuzzi) (1584 - 1647)
No full textU prilogu su predstavljeni neki već poznati, ali i do sada nepoznati podatci iz života hvarskoga kanonika Andrije Bartučevića (Andrea Bertuzzi), primarno na temelju historiografskih saznanja te njegove posljednje volje iz rujna 1647. pohranjene u Kaptolskom arhivu u Hvaru. Osim toga, naglasak u radu stavljen je na Bartučevićev utjecaj na neke aspekte ekonomskog, crkvenog, religioznog i kulturnog života u hvarskoj komuni krajem XVI. i prvoj polovici XVII. stoljeća. Na kraju se u prilogu u cijelosti donosi prijepis testamenta kanonika Andrije Bartučevića.The focus of this article is life and work of Andrew Bartučević, Canon of Hvar. Andrew is a descendant of the Bartučević noble family which originates from Apulia (Italy). He was born in 1584, and after his study in Italy (University of Bologna or Padova), he returned in Hvar and entered the canonical service on May 8, 1607. From 1613 until his death, he served as the operator of the Hvar Cathedral (church revenue collector and economic affairs supervisor). Bartučević was personally engaged in supervising the renovation and construction of the Hvar Cathedral (facade, apse) during the first half of the seventeenth century. He carefully supervised the masters, concluded contracts with craftsmen from Korčula and other places on the eastern Adriatic coast and in Venice, paid them compensation for the work performed, but also hired artists to make altars and altarpieces in Hvar Cathedral and the Dominican church of St. Mark. The article also contains a qualitative analysis of Bartučević\u27s last will, which shows that Canon Bartučević was also a talented entrepreneur who invested his income in the purchase of new residential and land real estate in the commune of Hvar (Stari Grad, Hvar, Vis), where he also cultivated vineyards. The wine from his vineyards brought him a good income. He also built a lime kiln on the cape of St. Pelegrin. He invested the proceeds in ordering works of art, but also took care of the spiritual goal and left a considerable amount to communal monks (Franciscans, Dominicans and Augustinians) and members of the Hvar Chapter to serve the masses pro remedio animae testatoris and his ancestors and benefactors. His testament (of September 20, 1647), which is kept in the Chapter Archive in Hvar, is a valuable source that witness ecclesiastical, economic, cultural and spiritual circumstances in contemporary Hvar. The author is analyzing this testament and at the end giving the full transcript
- …
